Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer Y Liu, J Wu, W Huang, S Weng, B Wang, Y Chen, H Wang Journal of translational medicine 18, 1-17, 2020 | 86 | 2020 |
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18. 2-targeted CAR-T against pancreatic cancer Y Liu, Y Sun, P Wang, S Li, Y Dong, M Zhou, B Shi, H Jiang, R Sun, Z Li Journal of translational medicine 21 (1), 255, 2023 | 45 | 2023 |
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer R Sun, Y Sun, C Wu, Y Liu, M Zhou, Y Dong, G Du, H Luo, B Shi, H Jiang, ... Molecular Therapy 31 (11), 3193-3209, 2023 | 24 | 2023 |
Integrated gene expression profiling analysis reveals probable molecular mechanism and candidate biomarker in anti-TNFα non-response IBD patients Y Liu, Y Duan, Y Li Journal of Inflammation Research, 81-95, 2020 | 18 | 2020 |
Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer S Ruixin, L Yifan, W Chuanlong, Z Min, L Hong, D Guoxiu, L Zhengyang, ... Biochemical pharmacology 212, 115536, 2023 | 13 | 2023 |
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors Y Sun, Y Dong, R Sun, Y Liu, Y Wang, H Luo, B Shi, H Jiang, Z Li Molecular Therapy-Oncolytics 25, 160-173, 2022 | 13 | 2022 |
GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma R Sun, Y Liu, Y Sun, M Zhou, Y Wang, B Shi, H Jiang, Z Li Acta Pharmacologica Sinica, 1-14, 2024 | 9 | 2024 |
Previous intestinal resection is associated with postoperative complications in Crohn’s disease: A cohort study Y Duan, Y Liu, Y Li Gastroenterology Research and Practice 2020 (1), 2194382, 2020 | 7 | 2020 |
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer S Ruixin, L Yifan, S Yansha, Z Min, D Yiwei, H Xiaoli, S Bizhi, J Hua, ... British Journal of Pharmacology 181 (22), 4628-4646, 2024 | | 2024 |